Belgium· BE-AMP-SAM534871-00
Oxybate Mylan 300 mg/ml
A sodium oxybate product containing sodium oxybate, registered in Belgium by Viatris GX. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Sodium oxybate is registered in 14 of 19 countries.
Countries holding a registration under ATC N07XX04 (sodium oxybate), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Sodium oxybate · ATC N07XX04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Sodium Oxybate
- Manufacturer
- Viatris GX
- Country
- Belgium (BE)
- ATC code
- N07XX04
- ATC class
- Sodium oxybate
- Defined daily dose
- 7.5 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
65 interactions on record for sodium oxybate.
Graded by severity as the source publishes them — 54 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sodium oxybate · interactions on record
65 records
- 54 severe
- 11 moderate
Most severe, free to view
- MetoclopramideA03FA01severe
- ThiethylperazinA04AB03severe
- DiphenhydraminA04AB05severe
- DronabinolA04AD10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Sodium oxybate in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLumryzAvadel CNS Pharmaceuticals, LLC
- United KingdomSodium oxybate 500mg/ml oral solution sugar freeAS Kalceks
- GermanyNatriumoxybat AccordAccord Healthcare B.V.
- SwedenNatriumoxibat Kalceks 500 mg/ml Oral lösningAS KALCEKS
- FinlandNatriumoksibaatti AscendAscend GmbH
- NorwayNatriumoksybat KalceksAS Kalceks
- CzechiaSODIUM OXYBATE KALCEKSAS Kalceks, Riga
- IrelandSodium oxybate 500 mg/ml oral solutionAS Kalceks
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Alcover, Natriumoxybat Kalceks
- Czechia · Sodium Oxybate Kalceks
- Germany · Natriumoxybat Accord, Natriumoxybat Aristo
- Denmark · Natriumoxybat, Natriumoxybat Kalceks
- Estonia · Sodium Oxybate Kalceks
- Spain · Anartex, Oxibato De Sodio Kalceks
- Finland · Natriumoksibaatti Kalceks, Natriumoxibat Reig Jofre
- France · Gamma-Oh, Oxybate De Sodium Kalceks
- United Kingdom (Northern Ireland) · Sodium Oxybate As Kalceks, Sodium Oxybate Reig Jofre Uk
- Greece · Oxybatin
- Ireland · Sodium Oxybate As Kalceks
- Iceland · Xyrem
- Italy · Alcover, Sodio Oxibato Accord
- Liechtenstein · Xyrem
- Lithuania · Sodium Oxybate Kalceks
- Latvia · Nartex
- Netherlands · Natriumoxybaat Accord, Natriumoxybaat Aristo
- Norway · Natriumoksybat Kalceks, Oxiore
- Poland · Sodium Oxybate Accord
- Sweden · Natriumoxibat Kalceks, Natriumoxibat Reig Jofre
- Slovenia · Natrijev Oksibat Accord, Natrijev Oksibat Kalceks
- Slovakia · Sodium Oxybate Kalceks
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe0aa3b7-cc79-4137-bb44-bd822b47d658 GET /v1/drugs/fe0aa3b7-cc79-4137-bb44-bd822b47d658?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oral solution",
"source": "afmps",
"status": "REVOKED",
"name_en": "Oxybate Mylan 300 mg/ml",
"name_fr": "Oxybate Mylan 300 mg/ml",
"name_nl": "Oxybate Mylan 300 mg/ml",
"amp_code": "SAM534871-00",
"strengths": [
"300.0000",
"300.0000"
],
"pack_count": 1,
"substances": [
"Sodium Oxybate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Sodium Oxybate",
"authorisation_numbers": [
"BE534871"
]
}See everything about sodium oxybate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.